MacroGenics (MGNX) announced that effective as of August 13, Eric Risser has been appointed president, CEO and to the board of directors. Risser has served as COO at MacroGenics since 2022. Risser succeeds Scott Koenig, who is stepping down after serving as president and CEO for the past 24 years.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGNX:
- MGNX Earnings this Week: How Will it Perform?
- MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
- MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
- MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
- MacroGenics Advances Cancer Treatment with MGC026 Study Update